▲ Peaking
Business
Breaking: Vertex makes $10B deal for commercial endocrinology biotech Crinetics
Vertex’s $10 billion buy of Crinetics sparks intense focus on biotech M&A.
2 trends tracked about this subject — the full history, oldest to newest below.
Vertex’s $10 billion buy of Crinetics sparks intense focus on biotech M&A.
Eli Lilly reports positive initial Phase 1 clinical data for its $2.3 billion acquisition of Ajax Therapeutics' myelofibrosis treatment.